Epirubicin and peripheral ischaemia Patient Reports February 12, 2012

Epirubicin Side Effects Report #5492823-5
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 10, 2007. Female patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: atrial thrombosis, blood creatine phosphokinase increased, cardiac failure congestive, dilatation ventricular, intracardiac thrombus, leg amputation, parvovirus infection, peripheral ischaemia. Epirubicin dosage: 350 MG/M2. Patient recovered.

Epirubicin Side Effects Report #5514703-9
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 01, 2007. Female patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: atrial thrombosis, cardiac failure congestive, dilatation ventricular, peripheral ischaemia. Epirubicin dosage: DAILY DOSE:300MG/M2. Patient recovered.

Epirubicin Side Effects Report #5803874-2
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on June 26, 2008. Male patient, 61 years of age, weighting 198.4 lb, was diagnosed with prophylaxis of nausea and vomiting, oesophageal carcinoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood glucose increased, hyperglycaemic hyperosmolar nonketotic syndrome, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, CAPECITABINE, DOMPERIDONE, GRANISETRON. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5823685-1
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on July 14, 2008. Male patient, 61 years of age, weighting 198.4 lb, was diagnosed with oesophageal carcinoma, prophylaxis of nausea and vomiting and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood glucose increased, hyperglycaemic hyperosmolar nonketotic syndrome, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, CAPECITABINE, DOMPERIDONE, GRANISETRON. Patient was hospitalized and became disabled. Patient recovered.


Epirubicin Side Effects Report #5832609-2
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on July 23, 2008. Male patient, 61 years of age, weighting 198.4 lb, was diagnosed with oesophageal carcinoma, prophylaxis of nausea and vomiting and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood glucose increased, hyperglycaemic hyperosmolar nonketotic syndrome, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, XELODA, DOMPERIDONE, GRANISETRON. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5865991-0
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Aug 20, 2008. Male patient, 61 years of age, weighting 198.4 lb, was diagnosed with oesophageal carcinoma, prophylaxis of nausea and vomiting and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood glucose increased, hyperglycaemic hyperosmolar nonketotic syndrome, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, XELODA, DOMPERIDONE, GRANISETRON. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5777785-5
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on June 06, 2008. Male patient, 61 years of age, weighting 198.4 lb, was diagnosed with gastric cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood glucose increased, hyperglycaemic hyperosmolar nonketotic syndrome, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, XELODA, DEXAMETHASONE, GRANISETRON. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5788986-4
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 06, 2008. Male patient, 61 years of age, weighting 197.8 lb, was diagnosed with gastric cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: acidosis, hyperglycaemic hyperosmolar nonketotic syndrome, leg amputation, peripheral ischaemia. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, XELODA, DEXAMETHASONE, GRANISERON. Patient was hospitalized and became disabled. Patient recovered.